serena williams promoting glp 1 As athletes like promote Ozempic, experts say our obsession with weight loss is worse than ever Serena Williams Super Bowl LX

A study by researchers at the University of Pennsylvania found that people taking GLP-1 medications such as Ozempic, Wegovy, and Mounjaro faced a higher risk of developing alopecia than patients taking two other classes of diabetes drugs

Novo Nordisk has launched two large Phase III trials (EVOKE and EVOKE+) to assess whether semaglutide can slow cognitive decline in participants with early-stage Alzheimers disease

Saffron metabolites bind to biomolecules, protecting them from free radicals

Patients who have had mixed or unclear GLP-1 responses in the past, or who want biomarker context before starting treatment, may benefit from PlexusDx's genetic-pathway option

CJC-1295 offers more modest but potentially more sustainable effects by working within the body's natural systems

Because longterm safety data (especially for offlabel use) are limited, Better Med Spa screens thoroughly, avoids use in clients with active malignancy or uncontrolled metabolic disease, and monitors labs regularly